Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Sep 16;46(9):10259-10263.
doi: 10.3390/cimb46090611.

Current Landscape of Chronic Inflammatory Dermatoses: Where We Are and Where We Are Heading

Affiliations
Editorial

Current Landscape of Chronic Inflammatory Dermatoses: Where We Are and Where We Are Heading

Aleksandra Sójka et al. Curr Issues Mol Biol. .

Abstract

Chronic inflammatory dermatoses represent a heterogeneous group of skin disorders that are often characterized by persistent and relapsing inflammation, with complex underlying pathomechanisms [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Timeline of biological drugs and Janus kinase inhibitors acceptance by the Food and Drug Administration and the European Medical Agency. Created with BioRender.com.

References

    1. Biedermann T., Röcken M., Carballido J.M. TH1 and TH2 lymphocyte development and regulation of TH cell-mediated immune responses of the skin. J. Investig. Dermatol. Symp. Proc. 2004;9:5–14. doi: 10.1111/j.1087-0024.2004.00829.x. - DOI - PubMed
    1. Boffa M.J., Chalmers R.J. Methotrexate for psoriasis. Clin. Exp. Dermatol. 1996;21:399–408. doi: 10.1111/j.1365-2230.1996.tb00142.x. - DOI - PubMed
    1. Mozzanica N., Pigatto P.D., Finzi A.F. Cyclosporin in psoriasis: Pathophysiology and experimental data. Dermatology. 1993;187((Suppl. S1)):3–7. doi: 10.1159/000247285. - DOI - PubMed
    1. Wang C., Lin A. Efficacy of topical calcineurin inhibitors in psoriasis. J. Cutan. Med. Surg. 2014;18:8–14. doi: 10.2310/7750.2013.13059. - DOI - PubMed
    1. Di Martino V., Verhoeven D.W., Verhoeven F., Aubin F., Avouac J., Vuitton L., Lioté F., Thévenot T., Wendling D. Busting the myth of methotrexate chronic hepatotoxicity. Nat. Rev. Rheumatol. 2022;19:96–110. doi: 10.1038/s41584-022-00883-4. - DOI - PubMed

Publication types

LinkOut - more resources